Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Fibrinogen human is a hemostatic agent used for the treatment of acute bleeding episodes in patients with acquired or congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. It works by replacing a specific protein in the blood, fibrinogen (factor I), that helps with blood clotting.
- Mechanism
- Curator reviewed
Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. The native molecule is a dimer and consists of three pairs of polypeptide chains (Aα, Bβ and γ). Fibrinogen is a physiological substrate of three enzymes: thrombin, factor XIIIa, and plasmin. During the coagulation process, thrombin cleaves the Aα and Bβ chains releasing fibrinopeptides A and B (FPA and FPB, respectively). FPA is separated rapidly and the remaining molecule is a soluble fibrin monomer (fibrin I). The slower removal of FPB results in formation of fibrin II that is capable of polymerization that occurs by aggregation of fibrin monomers. The resulting fibrin is stabilized in the presence of calcium ions and by activated factor XIII, which acts as a transglutaminase. Factor XIIIa-induced cross-linking of fibrin polymers renders the fibrin clot more elastic and more resistant to fibrinolysis. Cross-linked fibrin is the end result of the coagulation cascade, and provides tensile strength to a primary hemostatic platelet plug and structure to the vessel wall.
- Primary indication
- Human fibrinogen is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.Curator reviewed · 12 structured indications
- First approval
- Canada, 2006 · United States, 1998 · European Union, 2016
- Also known as
- Coagulation Factor I · Factor I (fibrinogen) · Factor I human · Fibrinogen · Fibrinogen (human)
- Brand names
- Artiss
- Evarrest
- Evicel
- Fesilty
- Fibryga
- Riastap
- Tachosil
- Tisseel
- Veraseal
- Vistaseal
Resolves to
What you can answer from here — as of July 03, 2026
Which other approved drugs treat the same conditions as Fibrinogen human, and which companies have late-stage candidates in those indications?